Preliminary toxicity analysis of 3-dimensional conformal radiation therapy versus intensity modulated radiation therapy on the high-dose arm of the Radiation Therapy Oncology Group 0126 prostate cancer trial.
about
Evolving Paradigm of Radiotherapy for High-Risk Prostate Cancer: Current Consensus and Continuing ControversiesGaps between Evidence and Practice in Postoperative Radiotherapy for Prostate Cancer: Focus on Toxicities and the Effects on Health-Related Quality of LifeRole of Dose Intensification for Salvage Radiation Therapy after Radical ProstatectomyRationale and development of image-guided intensity-modulated radiotherapy post-prostatectomy: the present standard of care?Developing and Evaluating Multimedia Patient Education Tools to Better Prepare Prostate-Cancer Patients for Radiotherapy Treatment (Randomized Study).Phase I/II trial of definitive carbon ion radiotherapy for prostate cancer: evaluation of shortening of treatment period to 3 weeksEfficacy and toxicity of external-beam radiation therapy for localised prostate cancer: a network meta-analysisClinical characteristics and management of late urinary symptom flare following stereotactic body radiation therapy for prostate cancerSignificance of image guidance to clinical outcomes for localized prostate cancerHigh-dose-rate brachytherapy boost for prostate cancer: rationale and techniqueTransitioning from conventional radiotherapy to intensity-modulated radiotherapy for localized prostate cancer: changing focus from rectal bleeding to detailed quality of life analysisProctitis following stereotactic body radiation therapy for prostate cancerLate toxicity and quality of life after definitive treatment of prostate cancer: redefining optimal rectal sparing constraints for intensity-modulated radiation therapy.High dose versus conventional dose in external beam radiotherapy of prostate cancer: a meta-analysis of long-term follow-up.Quantifying Unnecessary Normal Tissue Complication Risks due to Suboptimal Planning: A Secondary Study of RTOG 0126.Preliminary patient-reported outcomes analysis of 3-dimensional radiation therapy versus intensity-modulated radiation therapy on the high-dose arm of the Radiation Therapy Oncology Group (RTOG) 0126 prostate cancer trial.Three-dimensional conformal arc radiotherapy using a C-arm linear accelerator with a computed tomography on-rail system for prostate cancer: clinical outcomes.Image-guided intensity-modulated radiotherapy of prostate cancer: Analysis of interfractional errors and acute toxicityRadiotherapy and Hormone Treatment in Prostate CancerThe Comparison of Stereotactic Body Radiation Therapy and Intensity-Modulated Radiation Therapy for Prostate Cancer by NCCN Risk Groups.Comparison of dosimetric parameters and acute toxicity after whole-pelvic vs prostate-only volumetric-modulated arc therapy with daily image guidance for prostate cancer.Intensity-Modulated Radiation Therapy with Stereotactic Body Radiation Therapy Boost for Unfavorable Prostate Cancer: A Report on 3-Year Toxicity.Immune Modulation by Androgen Deprivation and Radiation Therapy: Implications for Prostate Cancer Immunotherapy.Progress and controversies: Radiation therapy for prostate cancer.Stereotactic body radiation therapy (SBRT) for prostate cancer in men with large prostates (≥50 cm(3)).Potential applications of image-guided radiotherapy for radiation dose escalation in patients with early stage high-risk prostate cancer.Radiotherapy for high-risk prostate cancer.A Practical Approach to the Management of Radiation-Induced Hemorrhagic Cystitis.Clinical implementation of a knowledge based planning tool for prostate VMAT.The comparative oncologic effectiveness of available management strategies for clinically localized prostate cancer.An image-based method to quantify biomechanical properties of the rectum in radiotherapy of prostate cancer.A comparison of clinical outcomes between three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for prostate cancer.Reducing radiation-associated toxicity using online image guidance (IGRT) in prostate cancer patients undergoing dose-escalated radiation therapy.ACR Appropriateness Criteria® external beam radiation therapy treatment planning for clinically localized prostate cancer, part I of II.Acute and late urinary toxicity following radiation in men with an intact prostate gland or after a radical prostatectomy: A secondary analysis of RTOG 94-08 and 96-01.[Image-guided intensity-modulated radiation therapy decreases late gastrointestinal side effects after radiation therapy for prostate cancer].Intensity-modulated radiotherapy reduces toxicity with similar biochemical control compared with 3-dimensional conformal radiotherapy for prostate cancer: A randomized clinical trial.Consensus and differences in primary radiotherapy for localized and locally advanced prostate cancer in Switzerland: A survey on patterns of practice.Risk adapted dose-intensified postoperative radiation therapy in prostate cancer patients using a simultaneous integrated boost technique applied with helical Tomotherapy.Impact of androgen-deprivation therapy on the outcome of dose-escalation prostate cancer radiotherapy without elective pelvic irradiation.
P2860
Q26744606-9ED74774-7E3B-48B3-9D5A-9428290BDB60Q26751574-C5AC1DE1-90C8-4C65-8F20-B100157E030CQ26765872-0EC84D6B-B1A6-446D-8787-DE1C9201236DQ26774847-DB80E03D-C499-4B2B-B6BA-516FC370E911Q30151845-084C1AC2-25F6-465D-947D-14446A8437D9Q33613649-0819C5F3-EB05-4906-9AAC-D7E3603995E7Q33613683-D3B8FF2E-F38A-415F-9EC0-190A9B605D0EQ33659901-695D393B-E138-4E36-B7BF-98449BEF9721Q33993238-8E4E6069-447D-4A5C-9684-A9C5C8D30791Q34355194-C9AC9FD8-E058-4EF7-A8BD-86C45F2A0216Q34500966-2D18DF47-BA08-4C07-B2E5-E2F1065D4A64Q34748877-B0975CBD-5AD8-4BFE-A7CB-6B59BE535558Q35000485-E671B3E4-0312-4FF4-B7F5-5B4DE1679243Q35235550-FE3E9C14-72D7-4C75-A378-D4111CE0DBD8Q35607117-FBBD95A8-A260-484B-B9A9-3AC61E469F04Q35812261-39FB0154-A18B-44DD-9617-574CBB686CA0Q36156751-495A810A-B8B8-4651-9346-DA7D3792E532Q36480102-A5D5B906-6064-45D4-B182-8379CBB53A0FQ37176612-934EF00D-0C4E-4AD3-A15A-5F2F0FCDC7C0Q37195789-150B96B8-C641-400A-AAF2-0247A74307E8Q37601093-046F7813-3FEF-49D3-AA89-80FDBCAFB485Q37627132-1DAB8998-CE04-4F87-AE2C-F2C5F2491D4CQ37676065-E55D1550-6549-463F-B2D4-5FA4694A67C0Q38252429-75008433-F1C7-48FE-9E84-41274C3ACAB3Q38268325-961F7403-6AC3-46B0-959E-A041ABC85002Q38362692-01EBA18C-5B6D-4D0E-9803-19D02F2EE9FEQ38364578-AB6610B6-5090-4BF5-8045-EC3C4D83FEEFQ38566196-02E4456C-C0A0-489D-AE6E-228762D3E094Q38797630-A786564B-09EA-4066-84D6-AA0ADC140C6AQ38822554-9788A4CD-A2B2-4026-9DCE-1EA8D2889C73Q38982334-C1726B3D-FFEC-42D6-8AD2-3D34778BF1C7Q39252193-5624E786-D18A-438A-B595-50B47CC3F988Q39415628-39610874-80B8-4122-ADE8-5249665099D8Q39456200-8A6E782F-0EAC-4F96-B80E-33A281CA452CQ39628846-9743717E-FEEA-42F1-8ABC-4954966E2E79Q40412725-BCB344EB-649A-490B-8F73-BD7890B412D2Q40827296-87FAB71D-8839-4C3E-8814-E73019379FCAQ40927190-651F1DF3-CD35-409D-BD6A-4E473415809EQ41336766-F3A62EBA-A7BB-4632-A5C5-6E9FB68CB187Q41486881-CA4D7B17-83E3-4740-9298-4D7EA6032FD2
P2860
Preliminary toxicity analysis of 3-dimensional conformal radiation therapy versus intensity modulated radiation therapy on the high-dose arm of the Radiation Therapy Oncology Group 0126 prostate cancer trial.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Preliminary toxicity analysis ...... up 0126 prostate cancer trial.
@en
type
label
Preliminary toxicity analysis ...... up 0126 prostate cancer trial.
@en
prefLabel
Preliminary toxicity analysis ...... up 0126 prostate cancer trial.
@en
P2093
P2860
P1476
Preliminary toxicity analysis ...... up 0126 prostate cancer trial.
@en
P2093
Howard M Sandler
James M Galvin
Jean-Paul Bahary
Jeff M Michalski
Kathryn Winter
Matthew B Parliament
Walter R Bosch
P2860
P304
P356
10.1016/J.IJROBP.2013.07.041
P407
P577
2013-10-08T00:00:00Z